Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Clarametyx Biosciences, Inc.
Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress
Today 8:00 EDT
From
Clarametyx Biosciences, Inc.
Via
Business Wire
Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis
October 16, 2025
From
Clarametyx Biosciences, Inc.
Via
Business Wire
Clarametyx Biosciences Announces FDA Grant of Fast Track and Qualified Infectious Disease Product Designations for CMTX-101
August 04, 2025
From
Clarametyx Biosciences, Inc.
Via
Business Wire
Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2A Study Evaluating CMTX-101 for Infections Associated With Cystic Fibrosis
June 16, 2025
From
Clarametyx Biosciences, Inc.
Via
Business Wire
Clarametyx Biosciences Announces Progress on Study of Antibody Therapy CMTX-101 for Infections Associated With Cystic Fibrosis
October 17, 2024
From
Clarametyx Biosciences, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.